Roche Serbia

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2010, Roche had over 80’000 employees worldwide and invested over 9 billion Swiss francs in R&D. The Group posted sales of 47.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.

Roche is known as one as the oldest multinational companies in Serbia, having launched its first product roughly 80 years agao in the local language. Subsequently, Roche first opened a representative office in Serbia in 1991. In 2005, the company opened the local affiliate.

Type:	EXECUTIVE
Address:	Roche d.o.o., Milutina Milankovica 11a, 11070 Novi Beograd, Serbia
Website:	www.rochesrbija.rs
Phone:	+381 11 2022 803
Fax:	+381 11 2607 270